Advertisement

Pharmaceutical Chemistry Journal

, Volume 38, Issue 12, pp 645–647 | Cite as

Bioaccessibility of the new dipeptide nootropic drug noopept

  • S. S. Boiko
  • V. P. Zherdev
  • T. A. Gudasheva
  • R. U. Ostrovskaya
  • S. A. Korotkov
  • O. Yu. Kravtsova
Molecular-Biological Problems of Drug Design and Mechanism of Drug Action
  • 117 Downloads

Keywords

Organic Chemistry Dipeptide Nootropic Drug 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

REFERENCES

  1. 1.
    T. A. Gudasheva, T. A. Voronina, R. U. Ostrovskaya, et al., Eur. J. Med. Chem., 31(2), 151–157 (1996).CrossRefGoogle Scholar
  2. 2.
    R. U. Ostrovskaya, T. A. Gudasheva, T. A. Voronina, et al., in: Drugs for Humans, Moscow (1997), Issue 4, pp. 295–304.Google Scholar
  3. 3.
    S. S. Boiko, V. P. Zherdev, A. A. Dvoryaninov, et al., Eksp. Klin. Farmakol., 602), 101–104 (2000).Google Scholar
  4. 4.
    S. S. Boiko, R. U. Ostrovskaya, V. P. Zherdev, et al., Byul. Eksp. Biol. Med., 129(4), 426–428 (2000).Google Scholar

Copyright information

© Springer Science+Business Media, Inc. 2004

Authors and Affiliations

  • S. S. Boiko
    • 1
  • V. P. Zherdev
    • 1
  • T. A. Gudasheva
    • 1
  • R. U. Ostrovskaya
    • 1
  • S. A. Korotkov
    • 1
  • O. Yu. Kravtsova
    • 1
  1. 1.Zakusov Institute of PharmacologyRussian Academy of Medical SciencesMoscowRussia

Personalised recommendations